Simple Science

Cutting edge science explained simply

# Biology# Pharmacology and Toxicology

Advancements in Target Identification for Drug Development

New methods improve accuracy in identifying drug targets for better treatments.

― 5 min read


Target IdentificationTarget IdentificationInnovationstreatments.identification for effectiveNew approach refines drug target
Table of Contents

The world of medicine, especially when it comes to pharmaceuticals, has changed a lot over the years. New drugs and targeted treatments have emerged. However, despite these advancements, many patients still show different results when using these drugs, and sometimes they face unwanted side effects. This unpredictability is often due to several reasons, like not fully knowing what parts of the body the drugs should target, unexpected interactions with other proteins, and the unique makeup of each person's genes and environment. All these factors contribute to why many new drugs fail to reach the market.

This creates a giant need for accurately identifying which protein targets a drug should focus on. To tackle this, scientists have been trying out new methods to find better or different molecules that can work as medicines. One promising method is called phenotype-based Drug Screening. However, pinpointing exact protein targets in this method has proven to be a tough nut to crack in drug development.

The Importance of Target Identification

Identifying protein targets is essential in figuring out how drugs work to provide their benefits. It helps refine and develop therapies that are directed at specific biological targets. Being able to target drugs accurately increases their effectiveness and safety. It also allows researchers to repurpose existing drugs and provides insights into how multiple drugs can interact with various targets.

While there have been advancements in target identification technologies, challenges still exist. Traditional methods, such as affinity-based pull-down techniques, can miss proteins that interact with drugs only briefly or are present in tiny amounts. These methods also struggle to maintain the complex environment where these interactions occur.

To counter these issues, newer techniques have been developed without modifications to the target proteins. Some examples include:

  • Stability of Proteins from Rates of Oxidation (SPROX)
  • Drug Affinity Responsive Target Stability (DARTS)
  • Cellular Thermal Shift Assay (CETSA)
  • Thermal Proteome Profiling (TPP)

These new methods focus on how proteins stabilize when they bind to a drug, which helps preserve the natural setting of the cells. However, they still face challenges in detecting small changes in Protein Stability and are limited in how they work within living cells.

Proximity Labeling: A New Approach

Another exciting method in target identification is called proximity labeling (PL). This technique uses systems like APEX, BioID, and TurboID to study how proteins interact with each other. While these systems provide valuable insights, they also have the downside of labeling proteins in a non-specific and diffusive manner, making it hard to accurately identify the actual target proteins.

Innovations have emerged, like a non-diffusive PL system designed to improve how researchers tag proteins in living cells. By harnessing the abilities of a prokaryotic ubiquitin-like protein, this new approach aims to ensure better specificity and minimize unwanted interactions.

The enhanced system combines different proteins to help tag specific targets in the proximity of the drug, allowing a clearer picture of which proteins are affected by which drugs.

Application and Testing of the New System

After setting up the new system for target identification, researchers began testing it in various scenarios, including using existing drugs like dasatinib and hydroxychloroquine (HCQ). They discovered that the new system managed to identify both known and new protein targets effectively.

In one instance, the team found that dasatinib interacted with SEPHS2, a protein important in the process of making certain essential cell components. This finding could lead to new ways to treat diseases where this process is crucial.

Similarly, hydroxychloroquine was found to interact with VPS37C, which is involved in cellular processes. This information is valuable not just for understanding how drugs work but also for discovering other potential treatment strategies.

How the New System Works

To create an effective tagging system for identifying drug targets, researchers combined different proteins with a unique method to allow for close proximity labeling. This system can tag specific proteins based on their interaction with drugs.

The researchers started by selecting proteins designed to work together efficiently. Through testing and refining their methods, they ensured that the tags would only attach to the intended targets. They also made sure the system would work within the natural settings of cells.

The final result is a system that can be used in live cells and animal models, such as zebrafish, providing a robust method for uncovering how drugs interact with biological systems. This setup is particularly useful for studying how drugs can affect specific proteins without the interference that often comes with more traditional techniques.

The Benefits and Future of Target Identification

The new system not only simplifies the process of identifying drug targets but also provides a more accurate picture of how medications operate in real biological environments. This can potentially speed up the process of drug development and ensure better outcomes for patients.

By using methods like this, researchers can continue to improve our understanding of how drugs work and refine their approaches to making new treatments. Capturing the complex interactions between drugs and proteins in living systems will ultimately help develop superior therapies with fewer side effects.

Conclusion

In summary, the field of target identification has made significant strides thanks to innovative approaches like the new non-diffusive PL system. It allows for the precise identification of drug targets within living cells and provides better insights into drug mechanisms. The ability to use this method in various organisms enhances its potential impact on drug development and biomedical research. With continued research and testing, the insights gained from these methods can lead to new and improved therapies that can help many people.

In the world of science, the more we uncover, the more questions arise. This ongoing quest for knowledge must be approached with curiosity, patience, and perhaps a good cup of coffee. After all, understanding the secrets of life is no small task-especially when those secrets involve trying to figure out what our drugs are really doing!

Original Source

Title: Target protein identification in live cells and organisms with a non-diffusive proximity tagging system

Abstract: Identifying target proteins for bioactive molecules is essential for understanding their mechanisms, developing improved derivatives, and minimizing off-target effects. Despite advances in target identification (target-ID) technologies, significant challenges remain, impeding drug development. Most target-ID methods use cell lysates, but maintaining an intact cellular context is vital for capturing specific drug-protein interactions, such as those with transient protein complexes and membrane-associated proteins. To address these limitations, we developed POST-IT (Pup-On-target for Small molecule Target Identification Technology), a non-diffusive proximity tagging system for live cells, orthogonal to the eukaryotic system. POST-IT utilizes an engineered fusion of proteasomal accessory factor A (PafA) and HaloTag to transfer Pup to proximal proteins upon directly binding to the small molecule. After significant optimization to eliminate self-pupylation and polypupylation, minimize depupylation, and optimize chemical linkers, POST-IT successfully identified known targets and discovered a new binder, SEPHS2, for dasatinib, and VPS37C as a new target for hydroxychloroquine, enhancing our understanding these drugs mechanisms of action. Furthermore, we demonstrated the application of POST-IT in live zebrafish embryos, highlighting its potential for broad biological research and drug development.

Authors: Yingjie Sun, Changheng Li, Xiaofei Deng, Wenjie Li, Xiaoyi Deng, Weiqi Ge, Miaoyuan Shi, Ying Guo, Yanxun V Yu, Hai-Bing Zhou, Youngnam N Jin

Last Update: 2024-11-07 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.09.06.611731

Source PDF: https://www.biorxiv.org/content/10.1101/2024.09.06.611731.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles